The Interventional Neurology Market is growing alongside the rising need for advanced treatments for stroke, aneurysms, and other cerebrovascular disorders. The market was valued at USD 4 billion in 2025 and is projected to reach USD 7.8 billion by 2035, reflecting a 5.1% CAGR from 2026 to 2035.

New technologies are making interventional neurology more precise and efficient. AI, machine learning, robotics, advanced imaging, and improved neurovascular devices are increasingly being incorporated into treatment workflows to support physicians during complex procedures.

Major applications include thrombectomy, stenting, and aneurysm coiling. Catheters, coils, and stents form important product categories, while hospitals, specialty clinics, and ambulatory surgical centers remain key end-use settings.

North America leads the market, supported by sophisticated healthcare infrastructure and high adoption of advanced medical devices. Europe remains a strong market, while Asia-Pacific is expected to see increasing demand as healthcare investment and access to neurological treatment improve.

Future opportunities may center on robotic intervention, AI-powered treatment planning, advanced imaging, and next-generation neurovascular devices. The continued shift toward minimally invasive and patient-focused neurological care could create additional demand for innovative interventional technologies.